Soligenix grants director 78,947 stock options
A Soligenix director received 78,947 stock options at a $0.38 exercise price, vesting through late 2027.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
SOLIGENIX, INC. (SNGX) reported that director Robert J. Rubin received a grant of 78,947 stock options on September 17, 2026. The options have an exercise price of $0.38 per share, expire on September 16, 2036, and vest ratably on four dates through September 17, 2027.
Insider Trade Summary
Grant/Award: 78,947 shares
Grant/Award
1 txn
Insider
RUBIN ROBERT J.
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) F1 | 78,947 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 78,947 contracts (Direct)
Footnotes (1)
- F1. The stock option vests ratably on each of December 17, 2026, March 17, 2027, June 17, 2027 and September 17, 2027.
Key Figures
Options granted: 78,947 options
Exercise price: $0.38 per share
Underlying shares: 78,947 shares
+3 more
6 metrics
Options granted
78,947 options
Stock option grant to director on September 17, 2026
Exercise price
$0.38 per share
Conversion or exercise price of granted stock options
Underlying shares
78,947 shares
Common Stock underlying the stock option grant
Post-transaction option holdings
78,947 options
Total stock options held directly after the reported grant
Option expiration date
September 16, 2036
Expiration of the granted stock options
Vesting dates
December 17, 2026; March 17, 2027; June 17, 2027; September 17, 2027
Ratable vesting schedule for the option grant
Key Terms
Stock Option, exercise price, vesting, expiration date
4 terms
Stock Option financial
"The stock option vests ratably on each of December 17, 2026"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price": "0.3800""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vesting financial
"The stock option vests ratably on each of December 17, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
expiration date financial
"expiration_date": "2036-09-16""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did SOLIGENIX, INC. (SNGX) report for Robert J. Rubin?
Robert J. Rubin, a director of SOLIGENIX, INC. (SNGX), received a grant of 78,947 stock options on September 17, 2026. These options were awarded as a grant or other acquisition and are held directly.
What is the exercise price of the new SNGX stock options granted to the director?
The granted stock options have an exercise price of $0.38 per share. This is the price at which the director may purchase Soligenix common stock upon exercising the options before expiration.
How many SNGX options does the director hold after this Form 4 transaction?
Following this transaction, the director holds 78,947 stock options related to Soligenix common stock as reported. This entire amount stems from the September 17, 2026 grant disclosed in the filing.
When do the newly granted SNGX stock options vest?
The options vest ratably on four dates: December 17, 2026, March 17, 2027, June 17, 2027 and September 17, 2027. Each date represents a portion of the total grant becoming exercisable.
What is the expiration date of the SNGX options granted to the director?
The stock options granted to the director expire on September 16, 2036. After this expiration date, any unexercised options from this grant can no longer be exercised for Soligenix common stock.
Were the SNGX option transactions made under a Rule 10b5-1 trading plan?
The filing indicates that the Rule 10b5-1 checkbox is not affirmed, meaning this grant is not reported as made under a Rule 10b5-1 trading plan based on the provided data.
AI-generated analysis. How Rhea-AI works. Not financial advice.
